Gilead Sciences (NASDAQ:GILD) Earns Buy Rating from Analysts at Citigroup
Citigroup started coverage on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research note published on Thursday morning, Marketbeat reports. The brokerage issued a buy rating and a $125.00 price objective on the biopharmaceutical company’s stock. GILD has been the topic of a number of other reports. Barclays increased their target price on […]
More Stories
Theory Financial LLC Raises Stake in iShares MBS ETF (NASDAQ:MBB)
Theory Financial LLC grew its stake in iShares MBS ETF (NASDAQ:MBB – Free Report) by 2.5% during the 3rd quarter,...
Equity Investment Corp Sells 4,103 Shares of Old Republic International Co. (NYSE:ORI)
Equity Investment Corp lowered its holdings in Old Republic International Co. (NYSE:ORI – Free Report) by 38.9% during the third...
Aon plc (NYSE:AON) Stake Cut by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC lessened its holdings in shares of Aon plc (NYSE:AON – Free Report) by 2.4%...
Richard C. Young & CO. LTD. Sells 1,067 Shares of Fidelity MSCI Utilities Index ETF (NYSEARCA:FUTY)
Richard C. Young & CO. LTD. cut its holdings in Fidelity MSCI Utilities Index ETF (NYSEARCA:FUTY – Free Report) by...
Richard C. Young & CO. LTD. Sells 1,310 Shares of The Hershey Company (NYSE:HSY)
Richard C. Young & CO. LTD. reduced its stake in shares of The Hershey Company (NYSE:HSY – Free Report) by...
Mutual of America Capital Management LLC Has $10.85 Million Stock Holdings in KKR & Co. Inc. (NYSE:KKR)
Mutual of America Capital Management LLC lowered its stake in shares of KKR & Co. Inc. (NYSE:KKR – Free Report)...